A pharmaceutical company brought on a CRA consultant to estimate economic damages arising from alleged infringement and at-risk launch of a patented oral antihyperglycemic drug used in the management of type 2 diabetes. The alleged economic damages were estimated according to appropriateness and, if so, quantum of lost profits, price erosion, and reasonable royalty elements.
Google damages ruling may spur income approach usage
In “Google Damages Ruling May Spur Income Approach Usage,” written for Law360, Dr. Erin Crockett takes a closer look at the value of an income approach to...